These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1975956)
1. Evaluation of the pharmacological similarities between phenylpropanolamine and amphetamine: effects on schedule-controlled behavior. Wagner GC; Jarvis MF Synapse; 1990; 6(1):101-5. PubMed ID: 1975956 [TBL] [Abstract][Full Text] [Related]
2. Tolerance to d-amphetamine and lack of cross-tolerance to other drugs in rats under a multiple schedule of food presentation. Brocco MJ; McMillan DE J Pharmacol Exp Ther; 1983 Jan; 224(1):34-9. PubMed ID: 6848748 [TBL] [Abstract][Full Text] [Related]
3. Behavioral and neurochemical evaluation of phenylpropanolamine. Woolverton WL; Johanson CE; de la Garza R; Ellis S; Seiden LS; Schuster CR J Pharmacol Exp Ther; 1986 Jun; 237(3):926-30. PubMed ID: 3712285 [TBL] [Abstract][Full Text] [Related]
4. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [TBL] [Abstract][Full Text] [Related]
5. Interresponse time changes as a function of water deprivation and amphetamine. Brown BM; Seiden LS J Pharmacol Exp Ther; 1975 May; 193(2):701-12. PubMed ID: 1142113 [TBL] [Abstract][Full Text] [Related]
6. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression. Hsieh YS; Yang SF; Chiou HL; Kuo DY Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825 [TBL] [Abstract][Full Text] [Related]
7. The pharmacology of the anorexic effect of phenylpropanolamine. Wellman PJ Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250 [TBL] [Abstract][Full Text] [Related]
8. An examination of d-amphetamine self-administration in pedunculopontine tegmental nucleus-lesioned rats. Alderson HL; Latimer MP; Blaha CD; Phillips AG; Winn P Neuroscience; 2004; 125(2):349-58. PubMed ID: 15062978 [TBL] [Abstract][Full Text] [Related]
9. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. Robbins TW; Roberts DC; Koob GF J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587 [TBL] [Abstract][Full Text] [Related]
10. Effects of phencyclidine on schedule-controlled responding following neurotoxic lesions of the striatum. Carlson KM; Wagner GC Life Sci; 2005 Jun; 77(4):372-85. PubMed ID: 15894007 [TBL] [Abstract][Full Text] [Related]
11. Similarities between the stimulus properties of phenylpropanolamine and amphetamine. Lee F; Stafford I; Hoebel BG Psychopharmacology (Berl); 1989; 97(3):410-2. PubMed ID: 2497491 [TBL] [Abstract][Full Text] [Related]
12. Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules. Green TA; Gehrke BJ; Bardo MT Psychopharmacology (Berl); 2002 Aug; 162(4):373-8. PubMed ID: 12172690 [TBL] [Abstract][Full Text] [Related]
13. Effects of drugs on schedule-controlled behavior in rats during chronic haloperidol administration. Rastogi SK; McMillan DE J Pharmacol Exp Ther; 1985 Feb; 232(2):295-300. PubMed ID: 3968634 [TBL] [Abstract][Full Text] [Related]
14. Self-administration of phenylpropanolamine (PPA) by rats previously trained to self-administer amphetamine. Wellman PJ; Shelton K; Schenk S Pharmacol Biochem Behav; 1989 Sep; 34(1):187-91. PubMed ID: 2626448 [TBL] [Abstract][Full Text] [Related]
15. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment. Martin-Iverson MT; Yamada N; By AW; Lodge BA J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728 [TBL] [Abstract][Full Text] [Related]